Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of the⦠read more
Healthcare
Drug ManufacturersāSpecialty & Generic
16 years
USD
Exclusive to Premium users
$48.50
Price+0.66%
$0.32
$1.794b
Small
-
Premium
Premium
-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow Margin$227.661m
-
1y CAGR-
3y CAGR-
5y CAGR-$10.228m
-
1y CAGR-
3y CAGR-
5y CAGR-$0.30
-
1y CAGR-
3y CAGR-
5y CAGR$49.299m
$345.033m
Assets$295.734m
Liabilities$231.251m
Debt67.0%
7.2x
Debt to EBITDA-$34.382m
-
1y CAGR-
3y CAGR-
5y CAGR